Literature DB >> 13534249

Intrahepatic cholangiolitic hepatitis: its surgical significance.

B McSWAIN, J L HERRINGTON, W H EDWARDS, J L SAWYERS, W R CATE.   

Abstract

Entities:  

Keywords:  HEPATITIS

Mesh:

Year:  1958        PMID: 13534249      PMCID: PMC1450711     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Prolonged jaundice (over three months) occurring during chlorpromazine administration.

Authors:  I B BRICK; S V BUCKLEY
Journal:  Gastroenterology       Date:  1957-08       Impact factor: 22.682

2.  Cholangiolitic hepatitis.

Authors:  C S CAMPBELL
Journal:  Northwest Med       Date:  1956-08

3.  Cholangiolitic hepatitis, with special reference to its physiopathologic concept, diagnosis and therapy.

Authors:  E W LIPSCHUTZ; D CAPSON
Journal:  Ann Intern Med       Date:  1955-11       Impact factor: 25.391

4.  Intrahepatic cholestasis (cholangiolitis).

Authors:  H POPPER; P B SZANTO
Journal:  Gastroenterology       Date:  1956-12       Impact factor: 22.682

5.  Jaundice associated with chlorpromazine (thorazine) therapy.

Authors:  A G REDEKER; D C BALFOUR
Journal:  Gastroenterology       Date:  1955-11       Impact factor: 22.682

6.  Hepatitis with manifestations simulating bile duct obstruction; so-called cholangiolitic hepatitis.

Authors:  E A GALL; H BRAUNSTEIN
Journal:  Am J Clin Pathol       Date:  1955-10       Impact factor: 2.493

7.  Chlorpromazine (thorazine) hepatitis.

Authors:  G MCHARDY; R MCHARDY; S CANALE
Journal:  Gastroenterology       Date:  1955-08       Impact factor: 22.682

  7 in total
  2 in total

1.  [The clinical picture of primary fibrous bile duct stenosis].

Authors:  E Kern; K Beck; L Bianchi; H H Gruenagel; I Strauss; R Zwirner
Journal:  Langenbecks Arch Chir       Date:  1968

2.  Diagnosis and treatment of cholangiolitic hepatitis (primary biliary cirrhosis).

Authors:  W P Longmire; W L Joseph; P M Levin; S M Mellinkoff
Journal:  Ann Surg       Date:  1965-09       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.